Oral Lipid Based Formulations Enhancing the Bioavailability of Poorly Water-Soluble Drugs
F13
Regulatory and Scientific Impact of FDAMA
Global Fabry Disease Market 2015-2019
GRUPO GEDEON
Overview of BioMed Central’s portfolio of society journals
PHARMACOLOGY
Nanoparticle technology for_drug_delivery
Lessons in Specialty Data Integration: Best Practices for Small and Emerging Biopharma Companies
Cmt newsletter-spring-2015
Connecting the Dots for Fast-Track Approval for Rare Disease and Orphan Drug
One Step Closer to Personalized Health Marketing
